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1. Introduction
   Antibiotic resistance is now considered a major public 
health issue with reports of an increasing trend of 
resistance in clinical isolates[1]. Recently the acceptance 
of traditional medicine as an alternative form of health 
care and the development of microbial resistance to 
the available antibiotics have reaffirmed the need to 
probe the antimicrobial activity of medicinal plants[2]. 
Curcuma longa L. (C. longa ), popularly known as 
turmeric, has long been used as a spice in Southeast 
Asia. It has also been used in Oriental folk medicines 
to treat infectious diseases (e.g. sinusitis, cough), 
cholecystitis and cholangitis and used as a therapy for 
hepatic disorders, rheumatism and anorexia[3]. Previous 
works have shown that C. longa inhibited the growth 
of activity of some bacteria and fungi[4,5]. C. longa has 
been reported to show antibacterial activities against 
methicillin-resistant Staphylococcus aureus (S. aureus) 
and lower the minimum inhibitory concentrations (MICs) 
of β-lactams[6]. The water extract of C. longa inhibits the 
growth of Helicobacter pylori[7]. In a recent report, it has 
been observed that very low doses of plant extract were 
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effective against multidrug resistant clinical isolates[8]. 
However, little is known about the antimicrobial effects 
of C. longa on multidrug resistant strains. 
   Zingiber officinale Rosc. (Z. officinale) is a slender, 
perennial rhizomatous herb. A broad range of biological 
activities have been attributed to Z. officinale and these 
include insecticidal[9], antibacterial[10,11], antiprotozoal[12], 
antioxidant[13],  antiemetic[14,15],  antirhinovirus[16], 
immunomodulatory[17], and antihepatotoxic[18]. The herb 
Tinospora cordifolia (Menispermaceae) (T. cordifolia) 
belongs to a group of medicinal plant that grows in the 
tropical and subtropical regions of India. The herb is 
extensively used in the Indian System of Medicine; the 
extract of different parts of the herb has found wide use 
in variety of diseases. It is known for its antidiabetic[19], 
hepatoprotective[20],  and immunomodulatory[21,22]. 
Recently, Narayanan et al. reported the antibacterial 
activity of various medicinal plants including T. 
cordifolia against multidrug resistant uropathogens[23]. 
Compared to other two plants, very few reporting has 
been observed for T. cordifolia as antimicrobial agents. 
Moreover, very little is known about the comparative 
evaluation of antibacterial properties among these three 
plants against clinical bacterial isolates. So, the present 
study was intended to make a comparative evaluation of 
antibacterial properties of C. longa, Z. officinale and T. 
cordifolia against S. aureus, Pseudomonas aeruginosa 
(P. aeruginosa), Klebsiella pneumoniae (K. pneumoniae), 
Escherichia coli (E. coli), Bacillus subtilis (B. subtilis) and 
Proteus mirabilis (P. mirabilis) of clinical origin.
2. Materials and methods
2.1. Collection of plant materials and microbes
   C. longa, Z. officinale and T. cordifolia were selected 
from agricultural land neighboring Assam University, 
Silchar, Assam, India. Rhizome of C. longa and Z. 
officinale were then collected, whereas in case of T. 
cordifolia, the stem parts were collected. Collection of 
plant material was independent of season. All the plants 
sample specimens were maintained in the University 
Herbarium, Department of Life Science, AUS (Voucher 
No- TC 11.21A; CL 11.22, ZO 11.23). The microbial strains 
viz, S. aureus (SMCSA-324), P. aeruginosa (SMCPA-544), K. 
pneumoniae (SMCKP-121), E. coli (SMCEC-422), B. subtilis 
(SMCBS-111) and P. mirabilis (SMCPM-301) were collected 
from Microbiology Department of Silchar Medical College, 
Assam, India.
2.2. Plant extracts preparation for antimicrobial studies
   Four portions (100 g) of each T. cordifolia (stem parts), 
C. longa (rhizome parts) and Z. officinale (rhizome parts) 
were soaked separately in 1 000 mL of acetone (Merck), 
ethanol (Merck), methanol (Merck) and distilled water 
for 72 h at room temperature. For water extraction, 100 
g of each powdered plant sample was boiled in 1 000 mL 
of hot water for 60 min. The filtration of the extracted 
solution was done twice at first with Whatman No. 1 
paper (Merck) and after that the filtrate was again filtered 
with mixed cellulose ester membrane filter (0.30 µm pore 
size) (Merck). Following filtration of the extracts, the 
evaporation was done under reduced pressure[24]. From 
these extracted compounds, different concentrations were 
prepared for antibacterial studies (Table 1).
Table 1
Yield of plant extract using different solvents (g). 
Plant Methanol Ethanol Acetone Water
T. cordifolia 1.000 1.250 1.500 0.980
C. longa 0.800 0.845 0.956 0.782
Z. officinale 0.800 1.000 0.600 0.800
2.3. Disc diffusion method
   The paper disc diffusion method was used to determine 
antibacterial activity, which is based on the method 
described previously[25]. Whatman paper No. 1 filter 
paper was used to make sterile discs in order to screen 
for the antibacterial activities of C. longa, Z. officinale 
and T. cordifolia. Filter paper was punctured to the shape 
of commercial antibiotic disc and discs were autoclaved 
at 121 °C for 5 min. The sterile filter papers were then 
dipped into the solubilized extract solution at different 
concentrations. The suspension of bacteria culture was 
prepared according to the MacFarland standard 0.5 and 
layered onto the Mueller Hinton agar plates to produce 
the bacteria field. A series of sterile punctured filter 
papers containing the extract were placed on the bacteria 
field by a sterile forceps. Distilled water, ethanol, 
methanol and acetone were used as negative control 
while the commercial antibiotic discs viz, ampicillin, 
clindamycin, penicillin G, erythromycin, chloramphenicol 
and vancomycin were used as a positive. Finally, the 
plate was incubated at 37 °C and the zone of inhibition 
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was observed after 24-48 h. 
2.4. Determination of MICs and minimum bactericidal 
concentration (MBC) 
   Sensitivity of bacteria to different T. cordifolia 
extracts can be measured by using a tube dilution 
technique, which determines the MBC. These tests 
were done to determine the lowest concentration of T. 
cordifolia extract, where it can show the bactericidal or 
bacteriostatic effect. Each tube contained an inoculum 
density of 5伊105 CFU/mL of each of the test organisms. All 
organisms were grown in Mueller Hinton broth. Then, the 
suspension of all the six bacterial culture was added into 
tubes containing diluted sample of T. cordifolia extract 
(1-100 µg/ml). The dilution of the samples was done 
with Mueller Hinton broth. Finally, the tubes containing 
diluted sample of T. cordifolia and bacteria was then 
incubated overnight at 37 °C with constant shaking on the 
shaker. The growth of the microorganisms was determined 
by turbidity. Clear tubes indicated absence of bacterial 
growth. For every experiment, a sterility check (methanol, 
ethanol ,  acetone and medium),  negative control 
(methanol, ethanol, acetone, medium and inoculums) and 
positive control (methanol, ethanol, acetone, medium, 
inoculum and different standard antibiotics individually) 
were included. The MIC of the alkaloids was the lowest 
concentration in the medium that completely inhibited 
the visible growth. The solvent value was deducted 
accordingly to get the final results of activity. The MBCs 
were determined by inoculating the surfaces of Muller 
Hinton agar plates with 25 µL of samples taken from the 
clear tubes. After the bacterial suspensions had been 
fully absorbed into the agar, the plates were further 
incubated at 35 °C for 20 h and were examined for growth 
in daylight. The MBC 50% and 90% were defined as the 
concentration of drug that resulted 50% and 90% killing of 
the bacterium relative to the concentration of bacterium 
that was present in test wells at 0 h. The ATCC strains of S. 
aureus, P. aeruginosa, K. pneumoniae, E. coli, B. subtilis 
and P. mirabilis were purchased from HiMedia company 
and used as reference strains (data not shown). After the 
completion of experimental work, the used microbial 
strains, media and plastic wares were sterilized and 
discarded as per the guideline of institutional biosafety 
committee. 
2.5. Statistical analysis
   One way ANOVA was carried out to compare the 
difference between mean (n=3) MIC and MBC values for 
each plant extract against each resistant microbe.
3. Results 
   To determine the antimicrobial activity of C. longa, Z. 
officinale and T. cordifolia plant crude extract against 
six clinical isolates, zone of inhibition, MIC and MBC were 
measured. All the experiments were done in triplicate 
and results are expressed as mean依standard error mean. 
The comparative studies of different extracts against each 
bacterial strain were statistically analyzed by One way 
ANOVA. The antimicrobial study was carried out against 
B. subtilis, K. pneumoniae, P. mirabilis, S. aureus, P. 
aeruginosa and E. coli of clinical origin. All of these 
strains were found to be phenotypically resistant to 
multiple antibiotics and the resistant property of these 
selected microbial strains was established from lack of 
zone of inhibition as well as from the MIC, MBC values of 
multiple standard antibiotics (Table 2).
Table 2
Antibacterial activity of six standard antibiotics (30 µg) against 
microbial strains of clinical origin.
Bacteria CL PE CH ER AM VA
E. coli R R R R R R
P. aeruginosa R R R R S R
K. pneumonaie S R R R R S
S. aureus R R R R R R
P. mirabilis R R R S S R
B. subtilis S S S R R R
R: Resistant; S: Sensitive; CL: Clindamycin; PE: Penicillin G; 
CH: Chloramphenicol; ER: Erythromycin; AM: Ampicillin; VA: 
Vancomycin. Resistant: less than 15 mm of inhibiting zone and 
MBC>0.5 mg/mL; Sensitive: greater than 15 mm of inhibiting zone 
and MIC<0.1 mg/mL. 
3.1. Antibacterial effects of C. longa against six clinical 
isolates
   The MIC and MBC 90% values of different fractions of C. 
longa against B. subtilis, K. pneumoniae and S. aureus 
(Table 3) showed that the aqueous extract had highest 
antibacterial activity. In addition, the result of zone of 
inhibition confirmed that the aqueous extract of C. longa 
was more effective against these three strains than other 
extracts (P<0.000 1; Table 4). The value of MIC [(5.92依
0.04) µg/mL] and MBC 90% [(19.57依0.24) µg/mL] of different 
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fractions of C. longa against P. mirabilis (Table 3) showed 
that the ethanol extract had highest antibacterial activity 
as compared to other extracts which was confirmed 
from zone of inhibition (Table 4) against P. mirabilis of 
clinical origin [(20.67依0.59) mm] (P<0.000 1). The value of 
MIC [(7.27依0.05) µg/mL] and MBC 90% [(24.67依0.15) µg/mL] 
of different fractions of C. longa against P. aeruginosa 
(Table 3) showed that the acetone extract had highest 
antibacterial activity as compared to other extracts. The 
result of zone of inhibition [(17.17依0.49) mm] (Table 4) 
also confirmed that (P<0.000 1). The value of MIC [(7.58依
0.07) µg/mL] and MBC 90% [(21.73依0.14) µg/mL] of different 
fractions of C. longa against E. coli (Table 3) showed that 
the acetone extract had highest antibacterial. In addition, 
the result of zone of inhibition (Table 4) against E. coli of 
clinical origin also showed that the acetone extract of C. 
longa was more effective than other extracts (P<0.000 1). 
The MIC and MBC values of different extracts of C. longa 
against different bacterial strains ranged from 5 to 55 mg/
mL.
Table 4
Zone of inhibition (mm) against six microbial strains of clinical origin 
at (200-300 CFU) different extracts of C. longa at 30 g/disc.
Microbial strains Methanol extract Ethanol extract Aqueous extract Acetone extract
B. subtilis 21.17依0.44 15.17依0.6 13.67依0.88 10.33依0.17****
K. pneumoniae 20.67依0.59 16.50依0.41 15.00依0.47 11.17依0.36****
P. mirabilis 18.17依0.49 21.50依0.62 16.00依0.94   11.33依0.54***
S. aureus 19.17依0.36 15.67依0.54 13.83依0.14   12.33依0.72***
P. aeruginosa 10.33依0.27 12.17依0.49 13.17依0.36 17.17依0.49****
E. coli 10.40依0.33 10.83依0.36 11.67依0.27 17.50依0.62****
***: P<0.001, ****: P<0.000 1.
3.2. Antibacterial effects of Z. officinale against six clinical 
isolates
   From the MIC [(8.17依0.07) µg/mL] and MBC [(30.00依0.24) 
µg/mL] values of different extracts of Z. officinale against 
B. subtilis, the methanol extract had highest antibacterial 
activity as compared to other extracts (Table 5), where the 
acetone extract [(14.67依0.67) mm] at 30 µg showed highest 
inhibiting zone against this strain (Table 6). The aqueous 
extract of Z. officinale showed highest activity compared 
to other extracts, against three Gram positive bacteria viz. 
K. pneumoniae, P. mirabilis and S. aureus as was evident 
from the results of MIC, MBC and zone of inhibition (Tables 5 
and 6). After comparing the antibacterial activity (MIC, MBC 
and zone of inhibition) of different extracts of Z. officinale 
against two Gram negative bacteria (P. aeruginosa and 
E. coli), it was found out that acetone extract had highest 
activity (Tables 5 and 6). The MIC and MBC values of 
different extracts of Z. officinale range between 8 to 95 
µg/mL. This result suggests that polar fractions of Z. 
officinale have higher antibacterial activity against Gram 
positive bacteria where less polar fraction of Z. officinale 
is more active against Gram negative bacteria. C. longa 
also showed the same trends of antimicrobial results as Z. 
officinale against these six clinical isolates.
Table 6 
Zone of inhibition (mm) against six microbial strains of clinical origin at (200-
300 CFU) different extracts of Z. officinale at 30 µg/disc.
Bacterial strains Methanol extract Alcohol extract Acetone extract Aqueous extract
B. subtilis 11.33依0.54 10.67依0.67 14.67依0.67 12.00依0.00
K. pneumoniae 12.33依0.27 12.33依0.33 12.33依0.17 12.67依0.41
P. mirabilis 11.67依0.54 11.17依0.44 10.67依0.44 12.13依0.24
S. aureus 10.33依0.27 12.17依0.44 12.50依0.50 10.73依0.50
P. aeruginosa 13.67依0.72 11.67依0.67 11.67依0.44 11.43依0.23
E. coli 11.33依0.27 10.67依0.33 12.67依0.33 10.57依0.35
Table 3 
MIC and MBC (mean依SEM) of different extracts of C. longa against six microbial strains of clinical origin (µg/mL).
Microbial strains Methanol extract Ethanol extract Aqueous extract Acetone extract
MIC MBC 50% MBC 90% MIC MBC 50% MBC 90% MIC MBC 50% MBC 90% MIC MBC 50% MBC 90%
B. subtilis 6.62依0.16 20.25依0.12 26.83依0.14 11.64依0.11 30.42依0.18 42.50依0.41 6.50依0.08 16.33依0.27 20.83依0.14  7.43依0.05 13.67依0.14 24.75依0.12****
K. pneumoniae 12.13依0.11 30.17依0.36 41.77依0.12 12.12依0.12 34.38依0.18 44.62依0.16 6.80依0.13 13.70依0.09 21.39依0.16 14.72依0.08 40.57依0.28 52.85依0.37****
P. mirabilis 12.43依0.11 27.83依0.14 33.9依0.08  6.52依0.11 13.8依0.13 18.97依0.12 5.92依0.04 10.37依0.19 19.57依0.24  7.60依0.07 14.13依0.47 21.77依0.12****
S. aureus 12.68依0.08 26.07依0.05 33.83依0.07 12.44依0.09 26.75依0.31 41.83依0.14 6.77依0.15 13.77依0.12 21.65依0.10 14.43依0.08 29.82依0.08 49.78依0.01****
P. aeruginosa 9.33依0.14 18.60依0.08 28.83依0.07 10.67依0.27 22.87依0.06 32.73依0.10 14.08依0.18 28.87依0.05 48.10依0.45  7.27依0.05 14.80依0.09 24.67依0.15****
E. coli 12.62依0.06 23.67依0.27 43.67依0.27 12.09依0.08 24.93依0.05 42.60依0.25 12.73依0.05 25.00依0.09 44.47依0.20  7.58依0.07 14.53依0.24 21.73依0.14****
****: P<0.000 1.
Table 5
MIC and MBC (mean依SEM) of different extract of Z. officinale against six microbial strains of clinical origin (µg/mL).
Microbial strains Methanol extract Ethanol extract Aqueous extract Acetone extract
MIC MBC 50% MBC 90% MIC MBC 50% MBC 90% MIC MBC 50% MBC 90% MIC MBC 50% MBC 90%
B. subtilis 8.17依0.07 25.25依0.35 30.00依0.24 10.67依0.27 28.60依0.31 36.8依0.16 11.50依0.41 31.17依0.14 45.57依0.24 10.50依0.24 29.70依0.05 40.08依0.07****
K. pneumoniae 16.40依0.17 45.57依0.24 61.83依0.14 17.63依0.26 52.30依0.13 66.4依0.70 15.80依0.13 42.67依0.27 53.60依0.25 21.85依0.06 52.73依0.35 77.85依0.06****
P. mirabilis 20.50依0.24 52.33依0.27 74.33依0.27 23.50依0.24 60.83依0.36 81.25依0.20 19.25依0.20 46.67依0.27 65.67依0.54 27.90依0.08 73.67依0.54 94.23依0.51****
S. aureus 18.27依0.22 51.33依0.27 64.50依0.36 20.32依0.18 58.52依0.24 67.50依0.24 13.13依0.11 39.33依0.27 45.67依0.72 22.80依0.30 61.90依0.08 75.93依0.48****
P. aeruginosa 16.13依0.11 41.87依0.11 44.67依0.27 18.90依0.08 47.30依0.25 52.83依0.36 21.33依0.54 44.77依0.12 55.87依0.38 11.53依0.38 35.93依0.43 40.28依0.42****
E. coli 26.33依0.98 60.67依0.54 86.50依0.62 34.00依0.94 84.33依0.27 94.17依0.49 20.17依0.49 64.33依0.27 78.20依0.34 13.33依0.36 37.50依0.85 50.50依0.62****
****: P<0.000 1.
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3.3. Antibacterial effects of T. cordifolia against six clinical 
isolates
   Unlike the antimicrobial results of C. longa and Z. 
officinale against these selected clinical isolates, entire 
extract of T. cordifolia did not show the antibacterial 
effect. The aqueous extract of T. cordifolia only showed the 
antibacterial effect (Tables 7 and 8) against these microbial 
strains and also higher MIC and MBC values as compared 
to C. longa and Z. officinale. The MIC and MBC values of 
aqueous extract against six clinical isolates ranged from 25 
to 125 µg/mL. 
Table 7 
MIC and MBC (µg/mL) of aqueous extract of T. cordifolia against six microbial 
strains of clinical origin (200-300 CFU).
Microbial strains MIC MBC 50% MBC 90%
B. subtilis 27.83依3.34 66.67依0.27 80.50依0.41
K. pneumoniae 10.17依0.36 31.50依0.24 36.67依0.27
P. mirabilis 10.97依0.45 34.67依0.54 40.33依0.27
S. aureus  7.50依0.41 21.50依0.62 27.00依0.47
P. aeruginosa 37.07依0.48 86.83依0.14 96.93依0.47
E. coli 43.50依0.26      100.27依0.73 124.57依0.71
Table 8
Zone of inhibition (mm) by aqueous extract of T. cordifolia at 30 µg/disc 
against six microbial strains of clinical origin (200-300 CFU).
B. subtilis K. pneumoniae P. mirabilis S. aureus P. aeruginosa E. coli
29.50依0.24 23.33依0.54 31.00依0.47 23.50依0.62 15.93依0.52 19.17依0.36
4. Discussion 
   Emergences of antibiotic resistance can develop from 
the selection of intrinsic resistance microbes or it can 
develop from environmental factor. Resistance is by 
definiting an in vitro phenomenon. The mechanisms of 
acquired resistance fall into one of the five categories, 
and these are 1) Enzymatic modification or destruction 
of the antibiotic, 2) Reduced antibiotic uptake into the 
bacterium, 3) Increased efflux of antibiotic from the 
bacterium, 4) Alteration or production of a new target site 
and 5) Over expression of the drug target[26]. In hospital 
associated microbial pathogen, the existence of drug 
resistant microbes has been increasing very rapidly. This 
situation generally develops by the misuse of standard 
antibiotics or selection of intrinsic resistant pathogen and 
subsequently transferring this character to other microbes 
via conjugation, transformation or transduction. Moreover, 
depending on the environment, microbes can also acquire 
resistance in response to particular antibiotic during 
nosocomial infection as a result of phenocopy. So, it is 
very important to measure the response of a particular 
microbial pathogen to a particular antibiotic in clinical 
isolates. Recent accumulation suggests that medicinal 
plants have been used against resistant microbial pathogen 
of clinical isolates and compared to single compounds, 
the plant extract has more profound pharmacological 
activity due to their multiple mechanism of action or due 
to synergistic interaction between the different compounds 
in a mixture[27]. In the present investigation, B. subtilis, 
K. pneumoniae, P. aeruginosa, S. aureus, P. mirabilis and 
E. coli of clinical origin were found to be phenotypically 
multidrug resistant and the resistance character of these 
microbes were established from the MIC, MBC (90%) values 
compared to standard antibiotics. The presence of resistant 
disposition of these six microbial strains might have arisen 
through nosocomial infection. 
   The present study also reports that B. subtilis, a Gram 
positive bacteria which can cause severe disease in 
immucompromised patients, is phenotypically resistant 
against erythromycin, ampicillin and vancomycin. 
Ampicillin is a beta-lactam antibiotic that has been used 
extensively to treat bacterial infections and it inhibits 
the enzyme transpeptidase thus blocking the final stage 
of cell wall synthesis. Erythromycin is a macrolide 
antibiotic that interferes with aminoacyl translocation 
by binding with the 50S subunit of 70S ribosome rRNA 
complex, preventing the transfer of the tRNA bound 
at the A site of the rRNA complex to the P site of the 
rRNA complex and thus preventing protein synthesis. 
Vancomycin prevents incorporation of N-acetylmuramic 
acid and N-acetylglucosamine peptide subunits into the 
peptidoglycan matrix, which forms the major structural 
component of Gram-positive cell walls. This study showed 
that B. subtilis was resistant to these standard antibiotics 
thus establishing the fact that this microorganism overcame 
the entire mechanism of action exerted by these antibiotics. 
However, the crude extracts of C. longa, Z. officinale 
and T. cordifolia were found to be effective against this 
phenotypically resistant B. subtilis, as was evident from 
MIC, MBC values. The comparative antibacterial studies 
among the different crude extracts of C. longa and 
Z. officinale individually, suggested that the aqueous 
and methanolic extracts of C. longa and Z. officinale 
respectively, had the highest effectiveness against this 
resistant B. subtilis. The antibacterial efficacy of C. longa 
and Z. officinale against B. subtilis were established to be 
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equal in range. However, only the aqueous extract of T. 
cordifolia showed antibacterial activity against B. subtilis. 
The possible mechanism of showing antibacterial activity 
by these three plants was either the compounds of these 
plants altering the modified form of targeted biomolecules 
or the mixture of compounds present in selected plants 
acted on multiple targets in this particular microbe.
   In addition to erythromycin, ampicillin and vancomycin, 
our study also reported that S. aureus of clinical origin, 
which can cause range of diseases starting from mild 
skin infection to severe toxic shock syndrome, was 
phenotypically resistant against clindamycin, penicillin, 
and chloramphenicol. Clindamycin is a lincosamide 
antibiotic having bacteriostatic effect. It is an inhibitor of 
bacterial protein synthesis that acts by impairing ribosomal 
translocation, in a way similar to macrolides. It does so by 
binding to the 50S rRNA of the large bacterial ribosome 
subunit. Penicillin is an antibiotic of β-lactam group. 
Bacteria constantly remodel their peptidoglycan cell walls, 
simultaneously building and breaking down portions of 
the cell wall as they grow and divide. β-Lactam antibiotics 
work by inhibiting the formation of peptidoglycan cross-
links in the bacterial cell wall. Resistance to these 
antibiotics by S. aureus creates a threat against the 
treatment of this bacteria associated diseases. However, 
the crude extract of C. longa, Z. officinale and T. cordifolia 
showed antibacterial activity against this antibiotic 
resistant S. aureus strain probably by overcoming or 
bypassing this entire resistance mechanism present in it. 
The trend of results showed by these plants against this S. 
aureus strain was similar to the result as obtained against 
B. subtilis. 
   The antibacterial activity of C. longa, Z. officinale 
and T. cordifolia against P. mirabilis, P. aeruginosa, K. 
pneumoniae and E. coli was also studied and it was found 
that this four Gram negative strains were resistant to almost 
all selected six standard antibiotics. But the acetone extract 
(less polar) of C. longa was exceedingly effective against 
Gram negative P. aeruginosa and E. coli. The acetone 
fraction of Z. officinale also showed highest activity against 
these two Gram negative strains as compared to other 
extracts. However, the activity of Z. officinale was observed 
to be subordinate as compared to C. longa. Comparative 
antibacterial studies among different extracts of C. longa 
and Z. officinale against other two selected Gram negative 
bacteria viz, K. pneumoniae and P. mirabilis showed 
contrasting results i.e. aqueous fraction (polar compounds) 
had the highest activity. In case of T. cordifolia, only the 
aqueous extract showed the antibacterial activity against 
all these selected six microbial strains but at thrice more 
concentration than C. longa and Z. officinale. Thus, it 
can be suggested that probably the relevant extracts of 
C. longa and Z. officinale penetrate the envelope’s outer 
membrane of these two Gram negative bacteria while the 
aqueous fraction of T. cordifolia follows an analogous 
kind of mechanism. Another promising rationalization of 
showing antibacterial activity against six phenotypically 
resistant strains by all these three plants was that probably 
it was the mixture of compounds present in the respective 
plant extracts that overcame the resistance mechanism 
by interacting with these microbes probable via multiple 
pathways and targets. 
   This study showed the efficacy of C. longa, Z. officinale 
and T. cordifolia  as antimicrobial agents against 
phenotypically resistant bacteria of clinical origin. 
Comparative antibacterial evaluation among these plants 
carried out in this study also showed that C. longa was 
more effective in killing these selected bacteria of clinical 
origin. Thus, the study not only explored the emergence 
of multidrug resistant bacteria in clinical isolates but also 
explored the fact that medicinal plants still have great 
reservoir of new antimicrobial agents, which are further 
needed to be explored in more details.
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